Varian repurchases stock, while Tengion raises funds with Medtronic investing
This article was originally published in Clinica
Radiotherapy specialist Varian Medical Systems is to buy back $280m of its common stock from the Bank of America under an accelerated share repurchase programme. The company will receive approximately 3.5 million shares, or 85% of the shares to be repurchased based on its closing share price on 23 February ($67.09).
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.